Objective
To achieve long-term capital growth by investing in biotechnology and other life sciences companies.
Management group
Schroder Investment Management
Launch date
06/05/1994
Domicile
United Kingdom
Fund manager
Ailsa Craig, Marek Poszepczynski
Dividend frequency
Semi-Annually
Wind-up provisions
The Association Articles of the company provide for Directors to put forward a proposal for the continuation of the company at the AGM at two-yearly intervals. The upcoming continuation vote is scheduled for the December 2023 AGM.
Market Cap (m) Total assets (m) Price (last close) NAV Discount / premium (%) Gearing (%) Dividend yield (%) Dividend dates Ongoing charge (%)
252.17 304.15 662.00 726.11 -8.83 6 4.26 Jul, Dec 1.4 (31/08/2023)
Scroll

Dividends

Dividends declared in last 12 months

Ex-Dividend date Payment date Dividend amount Special dividend Financial year
21/12/2023 26/01/2024 13.900 No 2024
27/07/2023 25/08/2023 14.200 No 2023
Scroll

Performance (%)

Return type 1 year 3 years 5 years 10 years
International Biotechnology Share price total return 5.5 -3.9 27.9 184.0
Biotechnology & Healthcare AIC sector Share price total return 2.9 -22.2 1.9 112.2
Scroll

Share structure

Number of shares
38,092,407

Traded volumes (number of shares)

  Yesterday 1 month 1 year 5 years
Total 36,658 1,381,265 12,652,813 83,216,560
Average N/A 65,775 50,011 65,940
Scroll

Traded values (m)

  Yesterday 1 month 1 year 5 years
Total 0.24 9.30 80.85 571.85
Average N/A 0.44 0.32 0.45
Scroll

Trading details

ISIN TIDM Traded currency Stock exchange
GB0004559349 IBT GBX London Stock Exchange - MAIN
Scroll

Top holdings

Data as at : 31/01/2024

Investment % of total assets
Vera Therapeutics Inc Class A 6.2
Gilead Sciences Inc 5.6
Sv Fund Vi Investment 5.1
Cytokinetics Inc 4.7
Supernus Pharmaceuticals Inc 4.6
Amgen Inc 4.3
Incyte Corp 4.0
United Therapeutics Corp 3.9
Biomarin Pharmaceutical Inc 3.6
Scb Sholo211123b 19-Jan-2024 6.460000% 20-Feb-2024 -10.6

Morningstar logo Data provided by Morningstar.

FE fundinfo logo Company documents provided by FE fundinfo.